Endocrine and reproductive manifestations of sarcoidosis

QJM: An International Journal of Medicine

Volumn 96, Issue 8, 2003, Pages 553-561

  Porter, N ^a   Beynon, H L ^b   Randeva, H S ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ANTIFUNGAL AGENT; ANTIMALARIAL AGENT; AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; CHLOROQUINE; COLECALCIFEROL; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GLUCOCORTICOID; HYDROXYCHLOROQUINE; IMIDAZOLE DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; KETOCONAZOLE; METHOTREXATE; PREDNISOLONE; STEROID;

ACUTE PANCREATITIS; ADRENAL INSUFFICIENCY; BRAIN BIOPSY; CALCIUM METABOLISM; CEREBROSPINAL FLUID EXAMINATION; CLINICAL FEATURE; DIET THERAPY; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; FEMALE; GENITAL SYSTEM DISEASE; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; HYPERTHYROIDISM; HYPOPHYSIS DISEASE; HYPOTHALAMUS DISEASE; HYPOTHYROIDISM; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS; VITAMIN D METABOLISM;

EID: 0041522703     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/hcg103     Document Type: Review

References (78)

1. Sharma OP. Sarcoidosis: Clinical Management. London, Butterworths, 1994:4.
2. Studdy PR. In: Weatherhall DJ, Ledingham JGG, Warrell DA, eds. Oxford Textbook of Medicine, 3rd edn. Oxford, Oxford Medical Publications: 2820.
3. DeRemee RA, Lufkin EG, etal. Serum angiotensin-converting enzyme activity. Its use in the evaluation and management of hypercalcaemia associated with sarcoidosis. Arch Intern Med 1985; 145:677-9.
4. Zeimer HJ, Greenaway TM, Slavin J, et al. Parathyroid-hormone-related protein in sarcoidosis. Am J Pathol 1998; 152:17-21.
5. Adams JS, Gacad MA. Characterisation of lα-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J Exp Med 1985; 161:755-65.
6. Zeimer HJ, Greenaway TM, Slavin J, Hards DK, Zhou H, Doery JC, Hunter AN, Duffield A, Martin TJ, Grill V. Parathyroid-hormone-related protein in sarcoidosis. Am J Pathol 1998; 152:17-21.
7. Sharma OP. Vitamin D, Calcium and Sarcoidosis. Chest 1996; 109:535-9.
8. Bell NH, Gill JR Jr, Bartter FC. On the abnormal calcium absorption in sarcoidosis: Evidence for increased sensitivity to vitamin D. Am J Med 1964; 36:500-13.
9. Basile JN, Liel Y, Shary J, Bell NH. Increased calcium intake does not suppress circulating 1,25-dihydroxyvitamin D in normocalcemic patients with sarcoidosis. J Clin Invest 1993; 91:1396-8.
10. Tomita A. Primary hyperparathyroidism associated with sarcoidosis. Nippon Ronsho 1995; 53:949-52.
11. Sinha RN. Long term management of hypercalcaemia in chronically active sarcoidosis. J Roy Soc Med 1997; 90:156-7.
12. Peel NFA, Moore DJ, Barrington NA, et al. Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 1995; 54:801-6.
13. Cooper C, Mitchell M, Wickham C. Rheumatoid arthritis, corticosteroid therapy and the risk of hip fracture. Ann Rheum Dis 1995; 54:49-52.
14. Verstraeten A, Dequeker J. Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids. Ann Rheum Dis 1986; 45:852-7.
15. Rizzato G, Montemurro L, Fraioli P. Bone mineral content in sarcoidosis. Semin Respir Med 1992; 13:411-23.
16. Adachi JD, Benson WG, Bianchi F, et al. Vitamin D and calcium in the prevention of glucocorticoid induced osteoporosis: a 3 year follow up. J Rheumatol 1996; 23:995-1000.
17. Adachi JD, Benson WG, Brown J, et al. Intermittent etidronate therapy to prevent corticosteroid induced osteoporosis. N Engl J Med 1997; 337:382-7.
18. Saag KG, Emkey R, Schnitzer TJ, et al. Alendronate for the prevention and treatment of glucocorticoid induced osteoporosis. Glucocorticoid-induced Osteoporosis Intervention Study Group. New Engl J Med 1998; 339:292-9.
19. Conron M, Young C, Beynon HLC. Calcium metabolism in sarcoidosis and it's clinical implications. Rheumatology 2000; 39:707-13.
20. Gonnelli S, Rottoli P, Cepollaro C. Prevention of corticosteroid induced osteoporosis with alendronate in sarcoid patients. Calcif Tissue Int 1997; 61:382-5.
21. Young C, Burrows R, Katz J, Beynon H. Hypercalcaemia in sarcoidosis. Lancet 1999; 353:374.
22. Bilezikian JP. Management of acute hypercalcemia. N Engl J Med 1992; 326:1196-203.
23. Chesney RW, Rosen JF, Hamstra AJ, Smith C, Mahaffey K, DeLuca HF. Absence of seasonal variation in serum concentrations of 1,25-dihydroxyvitamin D despite a rise in 25-hydroxyvitamin D in summer. J Clin Endocrinol Metab 1981; 53:139-42.
24. Bia MJ, Insogna K. Treatment of sarcoidosis-associated hypercalcaemia with ketoconazole. Am J Kidney Dis 1991; 18:702-5.
25. Adams JS, Sharma OP, Diz MM, Endres DB. Ketoconazole decreases the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia. J Clin Endocrinol Metab 1990; 70:1090-5.
26. O'Leary TJ, Jones G, Yip A, Lohnes D, Cohanim M, Yendt ER. The effects of chloroquine on serum 1,25-dihydroxyvitamin D and calcium metabolism in sarcoidosis. N Engl J Med 1986; 315:727-30.
27. Barre PE, Gascon-Barre M, Meakins JL, Goltzman D. Hydroxychloroquine treatment of hypercalcemia in a patient with sarcoidosis undergoing hemodialysis. Am J Med 1987; 82:1259-62.
28. Stern BJ, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations. Arch Neurol 1985; 42:909-17.
29. James DG, Sharma OP. Neurological complications of sarcoidosis. Proc Roy Soc Med 1967, 60:1169-70.
30. Vance ML. Hypopituitarism. N Engl J Med 1994; 300:1651-62.
31. Brust JCM, Rhee RS, Phank CR. Sarcoidosis, galactorrhoea and amenorrhoea: Two autopsy cases, one with Chiari-Frommel syndrome. Ann Surg 1977; 2:130-7.
32. Chiang R, Marshall MC, Rosman PM, Hotson G, Mannheimer E, Wallace EZ. Empty sella turcica in intracranial sarcoidosis. Arch Neurol 1984; 41:662-5.
33. Bleisch VR, Robbins SL. Sarcoid-like granulomata of pituitary gland: cause of pituitary insufficiency. Arch Intern Med 1952; 89:877-92.
34. Stuart C, Neelson F, Lebovitz E. Hypothalamic Insufficiency: The cause of hypopituitarism in sarcoidosis. Ann Intern Med 1978; 88:589-94.
35. Stuart C, Neelon F, Lebovitz H. Disordered Control of Thirst In Hypothalamic-Pituitary Sarcoidosis. N Engl J Med 1980; 303:1078-82.
36. Brunning PF, Koster HG, Hekster REM, Luyendijk W. Sarcoidosis presenting with diabetes insipidus followed up by acute cranial nerve syndrome. Acta Medica Scandinavia 1979; 205:441-4.
37. Luciani JC, Conte-Devolx B, Fourcade JC, Barjon P. Chronic hypernatraemia, hypovolaemia and partial hypopituitarism in sarcoidosis: a case report. Clin Nephrol 1980; 13:242-7.
38. Turkington RW, Macindoe JH. Hyperprolactinaemia in Sarcoidosis. Ann Intern Med 1972; 76:545-9.
39. Jawardi MH, Hanson TJ, Schemmel JE, Beck P, Katz FH. Hypothalamic sarcoidosis and hypopituitarism. Hormone Res 1980; 12:1-9.
40. Fery F, Plat L, Van De Bourne P, Cogan E, Mockel J. Impaired Counterregulation of Glucose in a Patient with Hypothalamic Sarcoidosis. N Engl J Med 1999; 340:852-7.
41. Veseky D, Maldonono A, Levey G. Partial Hypopituitarism and Possible Hypothalamic Involvement In Sarcoidosis. Am J Med 1977; 62:425-30.
42. Vesely DL. Hypothalamic sarcoidosis: A new cause of morbid obesity. South Med J 1989; 82:758-61.
43. Colover J. Sarcoidosis with involvement of the nervous system. Brain 1948; 71:451-5.
44. Jefferson M. Sarcoidosis of the nervous system. Brain 1957; 80:540-56.
45. Gjerse A, Kjerulif-Jensen K. Hypothalamic lesion caused by Boek's sarcoid. J Clin Endocrinol 1950; 10:1602-8.
46. Randeva HS, Davison R, Chamoun V, Bouloux PM-G. Isolated neurosarcoidosis-a diagnostic enigma: Case report and discussion. Endocrine 2002; 17:241-7.
47. Sherman JL, Stern BJ. Sarcoidosis of the CNS: comparison of unenhanced and enhanced MRI images. Am J Radiol 1990; 155:1293-301.
48. Gaines JD, Eckman PB, Remington JS. Low CSF glucose level in sarcoidosis involving the central nervous system. Arch Intern Med 1970; 125:333-6.
49. Schultz T, Miller WC, Bedrossian CW. Clinical application of measurement of angiotensin converting enzyme level. JAMA 1979; 242:439-41.
50. Oksanen V, Fyhrquist F, Somer H, Gronhagen-Riska C. Angiotensin converting enzyme in cerebrospinal fluid: a new assay. Neurology 1985; 35:1220-3.
51. 2-microglobulin in neurosarcoidosis. J Neurol Sci 1986; 73:79-87.
52. 2-Microglobulin. Sarcoidosis 1987; 4:13-17.
53. Li CY, Yam LT. Cytologic and immunohistochemical studies of cerebrospinal fluid in meningeal sarcoidosis. Acta Cytologica 1992; 36:963-7.
54. Agbogu BN, Stern BJ, Sewell C, Yang G. Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol 1995; 52:875-9.
55. Stem BJ, Schonfeld SA, Sewell C, Krumholz A, Scott P, Belendiuk G. The treatment of neurosarcoidosis with cyclosporine. Arch Neurol 1992; 49:1065-72.
56. Sharma OP. Neurosarcoidosis. A personal perspective based on the study of 37 patients. Chest 1997; 112:220-8.
57. Lower EE, Broderick JP, Brott TG, Baughman RP. Diagnosis and management of neurological sarcoidosis. Arch Intern Med 1997; 157:1864-8.
58. Lower EE, Baughmann RP. Prolonged use of methotrexate for sarcoidosis. Arch Intern Med 1995; 155:846-51.
59. Sharma OP. Effectiveness of Chloroquine and Hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement. Arch Neurol 1998; 85:1248-54.
60. Spencer J, Warren S. Boeck's Sarcoid: Report of a case, with Clinical Diagnosis Confirmed at Autopsy. Arch Intern Med 1938; 62:285-96.
61. Maycock RL, Bertrand P, Morrison CDE. Manifestations of sarcoidosis: analysis of 145 patients with a review of nine series selected from the literature. Am J Med 1963; 35:67-89.
62. Bacci V, Giammarco V, Germani G, Pelosio A, Nardi F. Hurthle Cell Hyperplasia and Sarcoidosis of the Thyroid. Arch Pathol Lab Med 1991; 115:1044-5.
63. Winnacker J, Becker K, Katz S. Endocrine Aspects of Sarcoidosis. N Engl J Med 1968; 278:483-90.
64. Brun J, Mouriquand C, Combey P, et al. Thyroidite sclereuse d'origine sarcoidosique avec myxoedeme et fibrose pulmonaire diffuse. Lyon Med 1959; 91:179-88.
65. Middleton WG, de Souza FM, Gardiner GW. Papillary carcinoma of the thyroid associated with sarcoidosis. J Otolaryngol 1985; 14:241-4.
66. Scadding JC. Sarcoidosis with special reference to lung changes. Br Med J 1950; 745-53.
67. Karlish AJ, MacGregor GA. Sarcoidosis, thyroiditis and Addisons disease. Lancet 1970; ii:330-3.
68. Papadopoulos K, Hornblad Y, Liljebladh H, Hallengren B. High Frequency of Endocrine Autoimmunity in Patients with sarcoidosis. Eur J Endocrinol 1996; 134:331-6.
69. Maycock RL, Bertrand P, Morrison CE, et al. Manifestations of sarcoidosis: analysis of 145 patients with a review of nine series selected from the literature. Am J Med 1963; 35:67-87.
70. Iwai K, Tachibana T, Hosoda Y, Matsui Y. Sarcoidosis autopsies in Japan: frequency and trend in the last 28 years. Sarcoidosis 1988; 5:60-5.
71. Siavelis H, Herrmann M, Aranha G, Garcia G, Eubanks T, Reyes C. Sarcoidosis and the pancreas. Surgery 1999; 125:456-61.
72. Noguchi H, Hirai K, Sea A, Yoshitake M, Sakai T, Abe H, Hidaka R, Tanikawa K. Sarcoidosis Accompanied by Pancreatic Impairment. Intern Med 1993; 32:15-20.
73. Turk C, Schacht M, Ross L. Diagnosis and Management of Testicular Sarcoidosis. J Urol 1986; 135:380-1.
74. Metcalfe MS, Rees Y, Morgan P, O'Reilly K, Sandu DPS. Sarcoidosis presenting as a testicular mass. Br J Urol 1998; 82:769-70.
75. Cho YS, Park JN, Suh JE, Rhu NS, Cho DI, Kim JW. A case of sarcoidosis accompanied azoospermia. Tuberculosis Resp Dis 1991; 38:179-85.
76. DiCarlo Jr FJ, DiCarlo JP, Robboy SJ, Lyons MM. Sarcoidosis of the uterus. Arch Path Lab Med 1989; 113:941-3.
77. Chalvardjian A. Sarcoidosis of the female genital tract. Am J Obstet Gynaecol 1978; 132:78-80.
78. Trimble EL, Saigo PE, Freeberg GW, Rubin SC, Hoskins WJ. Peritoneal Sarcoidosis and Elevated CA125. Obstet Gynaecol 1991; 78:976-7.